# Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation

Study · id `cardio:ct-nct01164592` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01164592](<https://clinicaltrials.gov/study/NCT01164592>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01164592

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 312 participants.

## Technical summary

Registry record NCT01164592. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2015-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 312 participants (enrolled count; ClinicalTrials.gov record NCT01164592, source copy `cardio:ctgov-nct01164592-2015-08-07`, retrieved 2026-10-26)
- Start date: 2012-08 (registry gives no type) (ClinicalTrials.gov record NCT01164592, source copy `cardio:ctgov-nct01164592-2015-08-07`, retrieved 2026-10-26)
- Primary completion: 2015-04 (actual) (ClinicalTrials.gov record NCT01164592, source copy `cardio:ctgov-nct01164592-2015-08-07`, retrieved 2026-10-26)
- Completion: 2015-06 (actual) (ClinicalTrials.gov record NCT01164592, source copy `cardio:ctgov-nct01164592-2015-08-07`, retrieved 2026-10-26)
- Countries: Australia; Czechia; Finland; France; Germany; Netherlands; Switzerland; United Kingdom (ClinicalTrials.gov record NCT01164592, source copy `cardio:ctgov-nct01164592-2015-08-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01164592-2015-08-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
- Acronym: MS
- Condition: Heart Failure
- Condition: Sleep Disorder
- Condition: Cheyne Stokes Respiration
- Intervention (Device): adaptive servoventilation (ASV)
- Lead sponsor: ResMed
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: ResMed (`cardio:org-resmed`)

## Provenance

Content hash: 6744d98aa8fe45df8838615c31e6df98abec1b01a52e75357810c07866098423
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
